Remove Events Remove Programs Remove Treatment
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Adverse events were mostly mild and resolved spontaneously. Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs. The 1mg dose showed a significant pain decrease compared to the placebo.

article thumbnail

IDPH approves four new conditions for medical cannabis treatment

Illinois News Joint

The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. To find cannabis-friendly events in Illinois, visit here.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals

Puff Puff Post

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.

Programs 108
article thumbnail

Cannabis or marijuana, medicinal plant or medical program?

Cannabis Life Network

medical marihuana defines varying programs…” Propaganda against cannabis or marijuana openly […]. The post Cannabis or marijuana, medicinal plant or medical program? Thankfully, the plant (cannabis or marijuana) regained some medical traction several decades later, but is cannabis not medicinal?

Medicine 108
article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025.

Programs 100
article thumbnail

Congressional Cannabis Caucus Co-Chairs Announced

NORML

Joyce becomes the first leader in the Caucus to come from a state that has yet to pass an adult-use regulatory program. The federal government’s interference in this arena has stifled important medical research, interfered with doctors and patients making treatment decisions and harmed state-legal businesses.

article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events. ABOUT WAKE NETWORK, INC.